Navigation Links
Epileptic Drug Found To Be Effective In Relieving Headache

Based on finding of a recent study researchers say the drug gabapentin (Neurontin) taken at 2,400 milligrams a day is an effective preventive // measure for people with chronic daily headaches.

Gabapentin is an approved anti-epileptic drug. Studies have also shown its success in treating other pain-related health issues like diabetic neuropathy, postherpetic neuralgia, and migraine headache. Since gabapentin often reduces migraines by more than 50 percent and chronic daily headaches often have migraine-like features, researchers in Australia conducted a double-blind, placebo-controlled study to determine the drug's specific effect on chronic daily headaches. This type of study is the gold standard of clinical research studies where neither the researchers nor the participants know who received the drug or an identical dummy substance, called a placebo.

For the study researchers recruited 133 patients who had headaches at least 15 days every month that lasted more than four hours at a time. The patients were randomly selected to receive gabapentin or a placebo for six weeks. After that period, none of the patients received either treatment for a week, and then each group switched to the opposite treatment for a second six weeks.

Results showed 36 percent of the patients taking 2,400 milligrams of gabapentin a day stopped having chronic daily headaches. Negative effects of the drug included vomiting, dizziness, dysarthria (problems speaking), sleepiness, and constipation.
'"/>




Page: 1

Related medicine news :

1. Epileptic Seizures Can Be Due to Heart Problem
2. Brain Septum Could Help In reducing Epileptic Seizures
3. Father Who Killed Epileptic Son Says He Misses Him
4. Epileptic Drug Found To Be Efficient As A Single Therapy
5. Simple Act of Brushing Your Teeth can Trigger an Epileptic Fit, Say Experts
6. Light-activated Compound May Be of Help for Epileptics in Future
7. Anti-Epileptic Drug Intake May Result In Children With Mental Retardation
8. Fluoride Found Effective in Osteoporosis
9. Implantable Contact Lens Found Safe and Effective
10. Cancer hazard Found With Animal-Based Nutrients
11. Processed Meat, Diabetes connection Found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: